eSignal IPO Calendar

Week of Expected Pricing	Pending
Company Name	AROG PHARMACEUTICALS, INC
Proposed Ticker	AROG
CUSIP	N/A
Business Description	A late-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing crenolanib in indications with high unmet need
Lead Underwriter	Citigroup Global Markets Inc ,Nomura Securities International, Inc. ,RBC Capital Markets, LLC
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A